Breaking News on Global Pharmaceutical Technology & Manufacturing

Hot Topics > Lifecycle management

News in brief

Novartis to reduce US sales force, days after denying job cut rumours

01-Dec-2010 - Novartis will reduce its US General Medicines sales force by 1,400 employees next year in preparation for impending patent loss for key products.

Celanese rolls out new customisable EVA excipient

08-Nov-2010 - Celanese has launched a new controlled-release EVA excipient and says developing enhanced formulations is key to a drugmaker’s competitive edge in today’s pharmaceutical market.

Endeavour sees recovery in intermediates sector

28-Oct-2010 - Drug industry demand for chemical intermediates and development projects has rebounded significantly in the last 12 months according to UK group Endeavour Specialty Chemicals.

Particle Sciences boost delivery tech offering with Solumer

20-Oct-2010 - Particle Sciences (PSI) becomes provider of Solumer drug delivery tech in deal with Israeli developer SoluBest.

Respiratory drugs a particular* opportunity for processing tech says Prosonix

19-Oct-2010 - Prosonix expects high demand for innovative particle processing technologies in the $24bn (€17bn) a-year respiratory pharmaceuticals market over the next few years.

NovaDel pilot PK study compares oral spray to Viagra

18-Oct-2010 - Data from a study comparing an oral spray formulation of sildenafil citrate to Viagra has been presented by NovaDel Pharma.

IMS prediction: Emerging markets front 5-7 % rise in drug sales for 2011

13-Oct-2010 - IMS Health predicts that global drug sales will increase 5 to 7 per cent next year, driven by development of innovative pharmaceuticals and growth of emerging markets.

Venus to supply docetaxel to Thailand

29-Sep-2010 - Venus Remedies is supplying docetaxel to Thailand after a compulsory license was issued to make the drug more affordable.

Large pharma firms interested in Stirling delivery tech

27-Sep-2010 - Stirling Products is in discussions with three large pharma interesting in accessing its HDA drug delivery platform.

Sun set on helping Taro, after buying controlling stake

23-Sep-2010 - India’s Sun Pharma has finally acquired a controlling stake in Israeli generics firm Taro Pharmaceutical Industries, significantly expanding its manufacturing capacity in North America.

Oracle adds pharma PLM for drug development & production

23-Sep-2010 - Oracle is revising its lifecycle management package to streamline processes including scale-up to commercial production and QbD implementation.

Q Chip scaling up cGMP production using new funding

15-Sep-2010 - Q Chip is using new funding to scale up its Q-Sphera technology for cGMP production of sustained release peptide and protein therapeutics.

Sanofi files sBLA with FDA for intradermal influenza vaccine

14-Sep-2010 - Sanofi Pasteur has filed a sBLA with the FDA for an intradermal form of influenza vaccine Fluzone using a microinjection system.


GSK taps Lonza for bio plant knowledge; sells R&D site to Galapagos

08-Sep-2010 - GSK will work with Lonza on the development of a UK biomanufacturing plant as part of a new MAb manufacturing contract announced today.

Actavis looks to enter biosimilars through acquisition

08-Sep-2010 - Actavis is looking to enter the biosimilars sector through the proposed acquisition of a stake in Biopartners.

Cipla looking at 25% Cipla Medpro investment

07-Sep-2010 - Indian drugmaker Cipla may invest in South Africa’s Cipla Medpro to boost manufacturing capacity and improve access to rapidly expanding African pharmaceutical markets.

Colorcon adds Turkey coating lab to tap regional markets

06-Sep-2010 - Colorcon says proximity to emerging drug manufacturing markets was key driver for new Turkey technical service lab.

NanGenex adds bench-top, pilot nano API production tech

01-Sep-2010 - NanGenex is introducing GMP bench-top and pilot plant reactors to scale-up its process for the continuous production of nanostructured active ingredients.

Genzyme rejects Sanofi’s $18.5bn bid; IPT looks at biotech’s turbulent 18-months

31-Aug-2010 - Genzyme has rejected Sanofi-Aventis' $18.5bn (€14.5bn) takeover bid, describing it as offering no improvement in price on the previous proposal and failing “to establish a basis for engagement.”

Spenser highlights chitosan advantages for XR delivery

31-Aug-2010 - Laboratory study shows succinyl-chitosan extended-release (XR) excipient could outperform commercially-available delivery technologies, says Spenser Pharmaceuticals.

Tech could allow more drugs to be delivered transdermally

26-Aug-2010 - Transdermal delivery of a broader range of therapeutics could be possible using microdevice fabrication technology Vyteris inked a deal to access.

News in brief

Biologics market worth $158bn by 2015, new report

19-Aug-2010 - Improving safety and efficacy coupled with drug industry desire for “stronger” patents will drive growth of the biologics sector over the next five years, according to new research.

Scolr cuts losses on reduced R&D spending, Q2 revs down

16-Aug-2010 - Scolr Pharma reduces losses despite drop in revenue by cutting spending on product R&D and operations.

Elan halts EDT sale, again; AD drug into Ph III

11-Aug-2010 - Elan puts plans to sell EDT delivery division on hold because market is not “conducive to an appropriate valuation.”

Vectura licenses dry powder tech to GSK

09-Aug-2010 - Respiratory formulations specialist Vectura has licensed two dry-formulation technologies to GSK, further strengthening its position in the $25bn (€19bn) asthma and COPD market.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...